On track to report data from Phase 1 clinical trial evaluating VG-3927 for the treatment of Alzheimer’s disease in 1Q 2025 –– Final analysis ...

Alto Neuroscience, Inc. (ANRO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

Mytos, a provider of automated cell manufacturing, has entered a manufacturing collaboration with Aspen Neuroscience, Inc. to ...

Mytos has entered into a manufacturing collaboration with Aspen Neuroscience Inc. to automate the manufacturing of autologous ...

Mytos, an innovative leader in automated cell manufacturing, has entered into a manufacturing collaboration with Aspen ...

Information Analysis (OTCMKTS:IAIC) reported in a Form 8-K filing to the Securities and Exchange Commission that Jon Olsen resigned from his role as a member of the board of directors at Firefly ...

Geode Capital Management LLC grew its holdings in shares of Alto Neuroscience, Inc. (NYSE:ANRO – Free Report) by 148.7% in ...

Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients ...

LOS ANGELES, CA / ACCESSWIRE / December 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Alto ...

Firefly Neuroscience, Inc. has entered into a securities purchase agreement with Helena Special Opportunities LLC, raising up to $2.4 million through a private placement of a convertible ...

TORONTO - Firefly Neuroscience, Inc. (NASDAQ:AIFF), a company specializing in artificial intelligence (AI) solutions for neurological and mental disorders, announced a... ByInvesting.com • Oct ...

Two new neuroscience studies offer fascinating answers ... The opinions expressed here by Inc.com columnists are their own, not those of Inc.com.